Trademarkia Logo

Canada

C$
Trademark Search in Canada
FERRING

View On IC.GC.CA

FERRING
SEARCHED

on 25 Apr 2025

Last Applicant/ Owned by

Ferring B.V.

Polarisavenue 144NL-2132 JX Hoofddorp

NL

Serial Number

2179099 filed on 14th Dec 2021

Correspondent Address

CASSELS BROCK & BLACKWELL LLP

Suite 3200, Bay Adelaide Centre - North Tower40 Temperance St.Toronto,

ONTARIO

CA

M5H0B4

FERRING

Trademark usage description

medical and clinical research services in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gast Read More

Classification Information

Class [042]
Medical and clinical research services in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; scientific research for medical purposes in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; providing scientific information in the field of medical disorders in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology and their treatment; provision of information and data relating to medical research and development; pharmaceutical research and development services; pharmaceutical products development in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; research of pharmaceuticals in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; conducting clinical trials for pharmaceutical products in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; computer technology consultancy and support services for the pharmaceutical and healthcare industries in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; design and development of software for use in the medical and pharmaceutical field related to endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; Software as a Service [SaaS] services for use in the medical and pharmaceutical field related to endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; Platform as a Service [PaaS] services for use in the medical and pharmaceutical field related to endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology

Classification kind code

11

Class [044]
Human healthcare services in the field of endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; providing information in the field of human health care related to endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology; medical services, consultancy, information and advisory services in the field of pharmaceutical products related to endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology and treatments; medical and health care information services related to endocrinology, urology, oncology, reproductive health, fertility, gynaecology, obstetrics, gastroenterology, orthopaedics and immunology

Classification kind code

11

Mark Details

Serial Number

2179099

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 17th Mar 2023		Search Recorded
Submitted for opposition 20
on 17th Mar 2023		Examiner's First Report
Submitted for opposition 223
on 17th Mar 2023		Total Provisional Refusal
Submitted for opposition 256
on 14th Feb 2023		Notification of Possible Opposition Sent
Submitted for opposition 48
on 17th May 2022		Agent Changed
Submitted for opposition 257
on 14th Apr 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 13th Apr 2022		Created
Submitted for opposition 31
on 13th Apr 2022		Formalized
Submitted for opposition 30
on 14th Dec 2021		Filed
Submitted for opposition 228
on 14th Dec 2021		International Registration